Education
About Us
Working with TipRanks
Follow Us
Allison Hagerman Insider Profile
4 Followers
Allison Hagerman, Senior Officer at Oncolytics Biotech, holds 67.88K shares in Oncolytics Biotech (Ticker: ONCY). Most recently, Allison Hagerman Bought $4,600 shares of Oncolytics Biotech on Jul 19, 2025 for an estimated value of 7.87K.
Allison Hagerman Oncolytics Biotech (ONCY)Senior Officer
Oncolytics Biotech (ONCY)
Senior Officer
Ranked #32,566 out of 102,596 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+48.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Allison Hagerman's holdings
Insider Roles
Senior Officer
Roles that Allison Hagerman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Allison Hagerman
Allison Hagerman's Trading History
List of latest transactions for each holding click on a transaction to see Allison Hagerman's performance on stock
You May Also Like
Allison Hagerman insider profile FAQ
What is the percentage of profitable transactions made by Allison Hagerman?
The percentage of profitable transactions made by Allison Hagerman is 50%.
What is the average return per transaction made by Allison Hagerman?
The average return per transaction made by Allison Hagerman is 48.50%.
What stocks does Allison Hagerman hold?
Allison Hagerman holds: ONCY stocks.
What was Allison Hagerman’s latest transaction?
Allison Hagerman latest transaction was an Informative Buy of $7.87K.
What was Allison Hagerman's most profitable transaction?
Allison Hagerman’s most profitable transaction was an Informative Buy of ONCY stock on June 18, 2022. The return on the trade was 97.10%.
What is Allison Hagerman's role in Oncolytics Biotech?
Allison Hagerman's role in Oncolytics Biotech is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.